How to buy Bone Biologics shares

Bone Biologics Corp (BBLG) is a publicly traded medical devices business based in the US. On 17 May Bone Biologics shares plunged 12.95% to a closing position of $0.168. However, over the last 12 months, Bone Biologics's share price has risen by a staggering 120.83% from $1.585. Bone Biologics is listed on the NASDAQ and employs 2 staff. All prices are listed in US Dollars.

Our top picks for where to buy Bone Biologics shares:

Best for

0% commission

Best for

Beginners

Best for

Beginner investments

BEST FOR

Transfer bonus

Fees for buying 100x Bone Biologics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform	Customer rating	Platform fee	Min. initial deposit	Trading fee estimate
	★★★★★	£0 - £9.99	No minimum	£1.66 £283.49 total	Go to site Capital at risk
	★★★★★	£0	$50	£1.41 £283.24 total	Go to site Capital at risk
	★★★★★	£0	£250	£9.50 £291.33 total	Go to site Capital at risk
	Not yet rated	£0	No minimum	£1.41 £283.24 total	Go to site Capital at risk
	★★★★★	£0	£1	£14.77 £296.60 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£0.28 £282.11 total	Read review Capital at risk

Full comparison of share dealing platforms

Alternative ways to invest in Bone Biologics

• Invest in Bone Biologics via a fund

  Buying shares in just one company can leave you more exposed to unexpected swings in the market than if you have a range of investments - a "diversified portfolio". Experts generally recommend having a broad mix of assets and funds that hold a ready-made portfolio of at least 50 different companies' shares, on the basis that drops in the value of some will be offset by rises elsewhere.

  Bone Biologics is a major part of the NASDAQ index, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy Bone Biologics stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

• See the technical analysis gauge

• See Bone Biologics share price (NASDAQ:BBLG)

  Use our graph to track the performance of BBLG stocks over time.

  Share price volatility

  Over the last 12 months, Bone Biologics's shares have ranged in value from as little as $0.14 up to $1.97. A popular way to gauge a stock's volatility is its "beta".

  Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bone Biologics's is 0.8121. This would suggest that Bone Biologics's shares are less volatile than average (for this exchange).

  To put Bone Biologics's beta into context you can compare it against those of similar companies.

  • ContraFect (CFRX.US): 0.4346
  • Fresh Tracks Therapeutics (FRTX.US): 0.5945
  • NanoVibronix (NAOV.US): 0.9078

• What's Bone Biologics price performance over time?

  Historical closes compared with the last close of $3.5001

  1 week (2023-05-24)	1,833.76%
  1 month (2023-05-01)	1,340.37%
  3 months (2023-03-03)	1,029.06%
  6 months (2022-12-01)	1,149.59%
  2 years (2021-05-27)	inf%
  3 years (2020-05-27)	inf%
  5 years (2018-05-27)	inf%

Invest in Bone Biologics shares

• Start investing from $50
• Pay no stamp duty on UK shares
• Commission-free trading. Other fees may apply.

Go to site

Capital at risk

Frequently asked questions

• Does Bone Biologics pay dividends?

  We're not expecting Bone Biologics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

  Currently 40.143% of Bone Biologics shares are held by insiders and 18.31% by institutions.

• How many people work for Bone Biologics?

  Latest data suggests 2 work at Bone Biologics.

• When does the fiscal year end for Bone Biologics?

  Bone Biologics's fiscal year ends in December.

• Where is Bone Biologics based?

  Bone Biologics's address is: 2 Burlington Woods Drive, Burlington, MA, United States, 01803

• What is Bone Biologics's ISIN number?

  Bone Biologics's international securities identification number is: US0980703039

• How to sell Bone Biologics shares

  It's as easy to sell Bone Biologics as it is to buy! Here's how to sell Bone Biologics that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your Bone Biologics shares. Your investment platform will let you know when your shares are sold

• Can you buy Bone Biologics shares with a debit card?

  Most share dealing providers in the UK will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy Bone Biologics shares?

  The easiest way to get hold of some Bone Biologics shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Bone Biologics shares.

• Do you need to complete a W8-BEN form if you want to invest in Bone Biologics

  If you're investing in a US stock, you'll need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for Bone Biologics?

  Financials

  Gross profit TTM	$0
  Return on assets TTM	-30.2%
  Return on equity TTM	-23.71%
  Profit margin	0%
  Book value	$0.389
  Market capitalisation	$3 million

  TTM: trailing 12 months